Paolo Tarantino, Research Fellow Dana-Farber Cancer Institute and Harvard Medical School, shared a post on X:
“Attending ASCO26? Make sure not to miss the educational session on novel ADCs on Saturday afternoon!
I’ll cover some recent hot topics in the field: combinations, sequencing, and strategies to get the most out of ADC treatment for solid tumors. Chaired by G. Curigliano.”
Other articles featuring Paolo Tarantino on OncoDaily.